Back

Which patients to refer to Hybrid AF Therapies: why and when?

13 April 2026 (14:50 - 15:00)
Organised by: Logo
Congress Presentation Part of: Targeting advanced atrial fibrillation: the Hybrid AF Therapies advantage Rhythm Control, Hybrid Therapy EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Philipp Sommer

Heart and Diabetes Center NRW, Bad Oeynhausen (Germany)

3 More presentations in this session

Presentation thumbnail
The advantage of epi-endocardial ablation in advanced atrial fibrillation
Doctor N. Sood (Fall River, US)
Slides Video
Presentation thumbnail
Durability matters: guideline changing data - long term results
Doctor A. Porta-Sanchez (Barcelona, ES)
Slides Video
Presentation thumbnail
Panel discussion
Video

Access the full session

Session thumbnail
Targeting advanced atrial fibrillation: the Hybrid AF Therapies advantage
Video

The Event

Event poster

EHRA 2026

13 April 2026 14:50 CET
You may be interested in
thumbnail
Congress Session
Targeting advanced atrial fibrillation: the Hybrid AF Therapies advantage
thumbnail
Congress Session
Debates in atrial fibrillation ablation
thumbnail
Congress Presentation
Review of atrial fibrillation guidelines - what they do and don't say about hybrid ablation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources